Search

Your search keyword '"G ALONGI"' showing total 7 results
Start Over Author "G ALONGI" Topic business.industry
7 results on '"G ALONGI"'

1. Capitalizing the blue world: What can we learn from an Eastern Mediterranean case study?

Author

Erminia Conti, Christian Mulder, G. Alongi, R. Turnaturi, and F. Toscano

Subjects
0106 biological sciences, Sustainable development, Ecology, business.industry, Environmental resource management, General Decision Sciences, 010501 environmental sciences, 010603 evolutionary biology, 01 natural sciences, Natural resource, Environmental accounting, Emergy, Sustainability, Marine protected area, Natural capital, Business, Productivity, Ecology, Evolution, Behavior and Systematics, 0105 earth and related environmental sciences
Abstract

Emergy analysis is an environmental accounting method used to comprehensively measure the sustainability of human and natural systems. This procedure is able to evaluate system’s relationship with its surroundings by considering all contributions from similar units. According to these objectives, Emergy analysis shape as a procedure able to provide integrated information about natural and human-driven resources supporting ecological functions and economic activities. In particular, Environmental Accounting Emergy-based provides a measure of Natural Capital (biophysical value of stocked biomass) in terms of natural resources consumption required to support generation of goods and fruition of services. The purpose of this work is to illustrate the procedural and methodological approaches, with field-testing of materials and methods, necessary to carry out an environmental accounting analysis in a Marine Protected Area (MPA). The investigation has been performed in a Mediterranean coastal MPA (“Isole Ciclopi”, SE Sicily, Italy) in order to provide a scenery of performance, impact and environmental sustainability of the activities carried on the MPA in relation to the renewable natural resources present. We show the extent to which a cost-benefit approach can assess the productivity of investing in environmental management and conservation. This integrated methodology may in fact help scientists, policy-makers and local managers to implement ecosystem administration according to the principles of sustainable development.

Published
2020

2. What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion

Author

G. Alongi, Francesco Amato, Sergio Mameli, C. Peruselli, S. Adamo, V. Minotti, L. Montanari, L. Lamarca, R. Pannuti, Franco Marinangeli, G. Moruzzi, W. Tirelli, L. Consoletti, Alessandro Valle, Danilo Miotti, Patrizia Romualdi, Guido Fanelli, Simeone Liguori, C Lo Presti, M. Parolini, P. Poli, Renato Vellucci, Sara Palermo, A. Maione, S. Marulli, Vellucci, R., Fanelli, G., Pannuti, R., Peruselli, C., Adamo, S., Alongi, G., Amato, F., Consoletti, L., Lamarca, L., Liguori, S., Lo Presti, C., Maione, A., Mameli, S., Marinangeli, F., Marulli, S., Minotti, V., Miotti, D., Montanari, L., Moruzzi, G., Palermo, S., Parolini, M., Poli, P., Tirelli, W., Valle, A., and Romualdi, P.

Subjects
medicine.medical_specialty, Alternative medicine, MEDLINE, Bioinformatics, Medication Adherence, 03 medical and health sciences, 0302 clinical medicine, Quality of life (healthcare), Pharmacotherapy, Health care, medicine, Pain Management, Surveys and Questionnaire, Pharmacology (medical), Medical prescription, Intensive care medicine, Pain Measurement, business.industry, Breakthrough Pain, Therapy in Practice, Analgesics, Opioid, Regimen, 030220 oncology & carcinogenesis, Practice Guidelines as Topic, Quality of Life, Neoplasm, business, Cancer pain, 030217 neurology & neurosurgery, Human
Abstract

Clinical management of breakthrough cancer pain (BTcP) is still not satisfactory despite the availability of effective pharmacological agents. This is in part linked to the lack of clarity regarding certain essential aspects of BTcP, including terminology, definition, epidemiology and assessment. Other barriers to effective management include a widespread prejudice among doctors and patients concerning the use of opioids, and inadequate assessment of pain severity, resulting in the prescription of ineffective drugs or doses. This review presents an overview of the appropriate and inappropriate actions to take in the diagnosis and treatment of BTcP, as determined by a panel of experts in the field. The ultimate aim is to provide a practical contribution to the unresolved issues in the management of BTcP. Five 'things to do' and five 'things not to do' in the diagnosis and treatment of BTcP are proposed, and evidence supporting said recommendations are described. It is the duty of all healthcare workers involved in managing cancer patients to be mindful of the possibility of BTcP occurrence and not to underestimate its severity. It is vital that all the necessary steps are carried out to establish an accurate and timely diagnosis, principally by establishing effective communication with the patient, the main information source. It is crucial that BTcP is treated with an effective pharmacological regimen and drug(s), dose and administration route prescribed are designed to suit the particular type of pain and importantly the individual needs of the patient.

Published
2016
Full Text
View/download PDF

3. Poster session Wednesday 11 December all day display: 11/12/2013, 09:30-16:00 * Location: Poster area

Author

S. Bosi, K. Wierzbowska-Drabik, W. Mullens, C. Goh, M. Abdel Ghany, J. Monmeneu, M. Perez Guillen, B. Zaborska, A. Di Lenarda, H. Mueller, M. Dluzniewski, R. Del Pozo Contreras, E. Laraudogoitia Zaldumbide, S. Yurdakul, O. Bech-Hanssen, M. Fernandez Garcia, R. Ippolito, C. Torromeo, B. Popescu, M. Cameli, P. Gaudron, M. Salvetti, R. Amano, E. Osto, P. Cabeza Lainez, G. Generati, C.H. Attenhofer Jost, J. Rueda-Soriano, F. Negri, T. Zielinski, M. El Serafi, Y. Agmon, I. Losano, Y. Qin, I. Castiglione, G. Santambrogio, A. Farhati, P. Menasche, K. Wdowiak-Okrojek, R. Juneja, G. Di Sciascio, N. Gaibazzi, D. Shin, F. Romeo, O. Huttin, P. Puddu, I. Ikonomidis, T. Baran, G. Tinica, A. Bel Minguez, E. Erdogan, M. Herruzo Rojas, I. Ter Horst, J. Suarez De Lezo, P. Bertrand, B. Putnikovic, O. Kretschmar, M. Gigli, F. Scholz, M. Lainscak, O. Rifaie, E. Tahirovic, A. Svanadze, G. Makavos, L. Iliuta, L. G. T. Zacharias, M. Baldelli, A. Porto, C. Di Nora, O. Asghar, A. Ramalli, W. Krol, M. Ahmed Abdel-Rahman, R. Autschbach, R. Tripodi, A. Budaj, V. Velagic, J. Kurcz, J. Aguilar, V. V. Kochmasheva, O. Enescu, H. Triantafyllidi, J. Diago, J. Park, J. Breur, F. Tona, M. Cikes, C. Maurea, T. Edvardsen, B. Igual Munoz, B. Michalski, J. Separovic Hanzevacki, A. Hagege, L. Gullestad, P. Sogaard, T. Fritz-Hansen, M. Rosca, A. Kuch-Wocial, C. Gonzalez Canovas, H. Uyarel, M. Guazzi, E. Pigatto, M. Carminati, R. Soyka, P. Tortoli, D. Djordjevic-Radojkovic, D. De Palma, L. Yuan, E. Mazzotta, M. Henein, D. Botezatu, J. Feng, L. Casteilla, C. Vignati, I. Burazor, M. Krestjyaninov, E. Zhdanova, D. Milicic, H. Mahfoudhi, A. Aziz, P. Trivilou, R. Hoffmann, A. Mysiak, C. Martini, K. Haugaa, F J V M Francisco Jose Valera Martinez, J. Lessick, M. Maccherini, C. Olympios, D. Mutlak, B. Haugen, M. Martin, A. Santoro, A. Orda, B. Skoric, S. Mihaila, M. Jung, G. Leenders, A. Bozkurt, M. Greco, M. Muratori, A. Subinas Elorriaga, Z. Radunovic, A. Osa-Saez, Z. Suciu, M. Alloni, F. Alamanni, J. Choi, J. Schwartz, M. Mericskay, M. Gurzun, D. Leone, P. Omede, J. Sawicki, D. Saura Espin, E. W. Remme, M. Bando, M. Varoudi, J. Gonzalez Carrillo, G. F. Gjerdalen, S. Aakhus, T. Bombardini, F. Veglio, L. Baduena, A. Calin, B. Austin, C. Viacroze, S. Aytekin, C. Santoro, I. Benedek, S. Comenale Pinto, F. Verbrugge, G. Styczynski, M. Sunbul, N. Pandian, T. Forster, J. Hisdal, S. Mondillo, M. Mourali, L. Magda, A. Quesada-Carmona, E. Caiani, G. Pavlidis, S. Ojeda, W. Ding, S. Ramakrishnan, L. Stefanczyk, A. Voumbourakis, A. M. Maceira Gonzalez, B. Igual, C. Selton-Suty, O. B. Kerbikov, B. Karolko, P. Lipiec, F. Meijboom, T. Andersen, M. Pellegrino, M. Lopez-Lereu, J. Kasprzak, Y. Zhao, R. Lang, M. Valdés Chávarri, J. Muir, A. Goetzenich, J. Hooper, M. Driessen, M. Greutmann, S. Casablanca, V. Curci, P. Szymanski, M. Cramer, F. Tosello, C. Gronlund, M. Chiavarelli, A. Cuvelier, P. Mogutova, F. Bandera, G. Greil, P. Fernandez Garcia, E.R. Valsangiacomo Buechel, M. Sobczynska, M. Kennedy, S. Boitard, D. Voilliot, H. Bellsham-Revell, A. Casacalenda, M. Sata, P. J. Sanchez Millan, S. Nishio, C. Chrisochoou, S. Mirfeizi, C. Beladan, K. Steine, M. Lisi, N. Krylova, A. Vlahovic-Stipac, S. Carerj, A. Oxenius, B. Geloneze, R. Calabro, E. Occhetta, P. Caso, R. Massey, B. Cengiz, M. Palencia-Perez, X. Xu, S. Brili, A. Evangelista, D. Mesa, S. Abadi, V. Reskovic Luksic, G. De La Morena Valenzuela, M. Anzini, S. Iliceto, A. Saxena, D. Vinereanu, G. Ussia, M. Sikora-Frac, S. Censi, R. Razavi, T. Wakatsuki, M. Romero, L. Punzi, C. Stefanadis, M. Pepi, E. Chueca Gonzalez, D. Rea, R. Chistol, I. Michalowska, N. Hayes, J. D'hoge, H. Aloui, D. Verhaert, I. Lekuona Goya, O. Sklyanna, K. Taamallah, S. Urheim, B. Natali, G. Sieswerda, M. Casartelli, D. Czarnecka, K. Lagerstrand, T. Chamova, E. Solberg, L. Sabia, M. Vatankulu, M. Obremska, D. Stolfo, H. Haouala, G. Bajraktari, G. Oria Gonzalez, I. Tournev, N. Olsen, O. R. Coelho, F. Spano, J. Yip, M. Anastasiou-Nana, A. Montero Argudo, S. Poli, J.-M. Sellal, P. Kulakowski, K. Kawecka-Jaszcz, O. Sonmez, M. Merlo, A. Chiru, A. Moreo, A. Colombo, R. Dahmani, W. Fehri, V. Rameev, D. Liu, A. Olszanecka, G. Placha, N. Kouris, A. Zaroui, J. Ljubas, G. Famoso, A. Massoni, S. Gao, M. Delgado, I Rodriguez Sanchez, R. Vazquez Garcia, D. Peluso, V. Planat-Benard, J. Cosin-Sales, E. Avenatti, V. Karidas, G. Sinagra, B. Jako, E. Alfonzetti, C. Hernandez Acuna, H. Farouk, D. Foley, M. Chmiela, P. Gripari, G. Patti, J. C. Pareja, Y. Hwang, C. Polte, D. Damaskos, D. Aronson, T. Rechcinski, T. Soeki, D. Simon, D. Anderson, N. Maurea, A. Brunet, C. Florescu, M. Marchei, A. Safarova, F. Cozzi, A. Neskovic, S. Mega, V. Miro-Palau, K. Darahim, B. Bednarz, A. Bitto, F. De Stefano, E. Kostarska-Srokosz, A. Nemes, G. Vizzari, T. Leiner, N. E. Hasselberg, P. Maffei, F. Mezni, Z. Bogdanovic, S. Kul, W. Kosmala, M. Rivero-Ayerza, G. Piscopo, M. Schiariti, V. Cammalleri, V. Kostopoulos, S. Storve, S. Stoerk, I. Planinc, B. Mutlu, J. R. M. Souza, J. J. Onaindia Gandarias, V. Donghi, H. Hamdi, G. Bagadur, A. Mabrouk Salem Omar, M. Floria, A. Klisiewicz, G. Barbati, A. Akhundova, A. Cacicedo, M. Annabi, D. Domingo-Valero, J. Simpson, J. Suarez De Lezo Herreros De Tejada, F. Cesana, D. Sergi, G. Alongi, M. Coppola, L. Grieten, G. Woo, L. Badano, G. Ertl, L. Caballero Jimenez, E. Donal, A. Kalapos, A. Anna Klisiewicz, H. Duengen, F. Mazuelos, U. Aguirre Larracoechea, N. Hasselberg, P. Domsik, L. Fusini, Z. Rezine, M. Misailidou, M. Rodriguez Serrano, D. Waterhouse, K. Keramida, F. Procaccio, G. Dell'era, N. Popova, F. Musumeci, D. Presutti, S F de Marchi, J. Van 'T Sant, S. Moisseyev, K. Paraskevopoulos, L. Molano, J. Estornell Erill, M. Gaspari, Z. Kobalava, I. Jedrzejewska, M. Galderisi, S. Neubauer, Piotr Hoffman, U. Cucchini, O. Miller, W. Kong, A. Swiatowiec, M. Vrolix, C. Grattoni, K. Broch, P. Ibrahimi, M. Garcia Navarro, R. Sheahan, P. Hoffman, M. Boratynska, J. Castillo Ortiz, R. Jankovic-Tomasevic, S. Wijers, P. Lindqvist, C. Tiu, V De Francesco, C. Goffredo, P. Agostoni, H. Yamada, V. Varano, T. Al-Maimoony, P. Wester, P. Schoof, J. Son, P. Piotr Szymanski, F. Righini, O. Agbulut, P. Nardinocchi, A. Aljalloud, I. Stankovic, O. A. Smiseth, L. Halmai, A. Bacaksiz, S. Rayasamudra, D. Filipiak, D. Muraru, D. Zysko, S. Muscoli, O. Goktekin, M. Przewlocka-Kosmala, S. Ryu, Z. Baricevic, M. Meine, J. Monmeneu Menadas, L. Gheorghe, A. Cremonesi, M. Lipczynska, A. Chaim, M. K. Smedsrud, M.D. Espinosa García, S. Mbarki, I. Stamatopoulos, L. Ling, F. Jashari, Y. Juilliere, D. Lahidheb, B. Mcadam, B. Bijnens, B. Pezo Nikolic, V. Guergueltcheva, J.-P. Vallee, O. Erdogan, R. Muscariiello, R. Mincu, M. Deljanin Ilic, C. Coppola, F. Arenga, J. Walker, M. Bono, J. Segura, R. Mechmeche, H. Uppal, S. Hayashi, A. Alhadad, M. Klinger, S. Herrmann, S. Snare, J. Estornell, M. Grecu, L. Lukasz Mazurkiewicz, J. Hotchi, C. Cipresso, E. Esposito, T. Marwick, N. Poteshkina, C. Zito, A. Squeri, V. Razin, I. Paraskevaidis, M. Jemaa, R. Marcun, R. Potluri, A. Anton Ladislao, F. Buendia-Fuentes, M. Pavlovic, S. Salinger-Martinovic, B. Igual-Munoz, T. Seoane, K. Mischke, G. Tamborini, G. Kim, A. Kardos, G. Pizzino, C. Matei, N. Hatam, V. P. Dityatev, H. Torp, A. Degiovanni, F. Rigo, M. Janulewicz, M. Gospodinova, M. Pan, P. Vallerio, F. Gaita, X. Jin, M. Akkaya, B. Pinamonti, A. Javanbakht, B. Lamia, N. A. Yaroshchuk, L. Musial-Bright, W. J. Nadruz, I. Papadakis, G. Kunszt, Y. Hirata, A. Shim, P. Maciejewski, M. Oliva Sandoval, S. Kadivec, E. Pilichowska-Paszkiet, F. Ranocchi, H. Neametalla, K. Hu, I. Sari, F. Carrasco, R. Ancona, R. Weber, R. Ivanova, A. Bartorelli, K. Eskesen, L. Teresi, P. Lopez Lereu, A. Holmgren, M. Kosnik, M. Turfan, M. Sobieszczanska-Malek, E. Kongsgaard, A. Bell, G. Hong, S. Denchev, A. Tasal, D. Mihalcea, F. Weidemann, G. De Caridi, A. Haggui, N. Hajlaoui, P. Alonso-Fernandez, A. Quattrone, M. Massetti, W. Braksator, I. Lekakis, T. Sahin, S. Carasso, F. Dassie, C. Bucca, C. Ginghina, C. A. Szmigielski, J. Baran, Z. Li, E. Aliot, A. Milan, J. Farkas, C. Smeets, D. Stanojevic, H. Dalen, S. Apostolovic, C. Moretti, G. Bruno, X. Zhao, E. Christoforatou, C. Arra, H. Poorzand, J. Ruvira, R. Matasic, F. Maffessanti, T. Vaugrenard, E. Szymczyk, R. Gimaev, S. Tellatin, C. Magnino, S. Velasco Del Castillo, P. Vandervoort, P. Doevendans, A. Dragan, M. Florescu, D. Carballo, P. Marino, D. Lovric, J. Nilson, L. Tong, H. Khorshid, R. Enache, A. Ruck, T. Benedek, R. Winter, M. Ruiz Ortiz, and E. Johansson

Subjects
medicine.medical_specialty, business.industry, medicine, Radiology, Nuclear Medicine and imaging, Medical physics, General Medicine, Session (computer science), Cardiology and Cardiovascular Medicine, business
Published
2013
Full Text
View/download PDF

4. Poster session Friday 7 December - PM: Effect of systemic illnesses on the heart

Author

G. Forleo, T. Henriques-Coelho, A. Kalogerakis, A. Nestoruc, R. Conti, G. Guzman Martinez, M. Ostojic, S. Aytekin, P. Margetis, D. Kremastinos, A. Hagege, M. Sunbul, L. Hazarapetyan, M. Fernandes, A. Pfuetzner, M. Akkaya, I. Paraskevaides, C. Zito, F. Castillo, D. G. Dorado, A Di Cori, O. Azevedo, M. Pizzarelli, TM Li Causi, A. Jaccard, A. Chilingaryan, A. Lourenco, B. Mutlu, E. Ermis, M. Martinek, D. Duval, L. Tumasyan, J. Thambo, P. Virot, P. De Araujo Goncalves, I. Sari, F. Colazzo, A. Stepura, M. S. Carvalho, B. Beleslin, P. Nihoyannopoulos, A. Corciu, E. Langesaeter, F. Kyndt, J. Schott, A. Diogo, G. Andersen, D. De Palma, H. Skulstad, P. Crea, S. Wirdeier, M. Olszowska, S. Castelvecchio, M. Muiesan, M. Kalantzi, G. Ertas, K. Branidou, I. Alvarez Pichel, E. Shkolnik, T. Schuster, M. J. Monaghan, A. Parkhomenko, V. Schiano Lomoriello, A. Ahmed, C. Jimenez Rubio, M. M. Urdaniz, A. M. Lesniak-Sobelga, G. Rubagotti, S. Gustavsson, Verena Stangl, F. Bertacchini, J. Otterstad, S. Matsushita, G. Macri, W. Streb, C. David, Y. Nogami, L. Faber, J. Kim, M. Chigira, M. Cusma-Piccione, S.-H. Shin, Cristina Maria Stanescu, M. Hlawaty, C. Napolitano, T. Kaier, S. Yurdakul, A. E. Masip, A. Zacharaki, S. Adawi, L. Menicanti, L. Tomkiewicz-Pajak, A. Patrianakos, S. Ercan, J. Stepanovic, F. Matei, U. Richter, E. Erdogan, R. Shaikh, A. Kepez, E. Soldati, K. Jarosz, M. Miceli, J. Grapsa, M. Cardoso, L. Boubrit, J. Singelton, M. Morenate, Henryk Dreger, I. Comanescu, L. Fontana, S. Morner, C. Agabiti Rosei, L. Brodin, J. Vaskelyte, E. Hamodraka, K. Uno, Fabian Knebel, R. Petraco, M. Komeda, L. Weinert, I. Daha, A. Shiran, V. Stinziani, I. Asmer, F. Antonini-Canterin, L. Iliuta, M. Rosca, P. Lindqvist, N. Cortez-Dias, E. Mueller, Z. Katidis, Y. Vasyuk, P. Rubis, R. Jonkaitiene, J. G. Acosta Velez, S. Lafitte, K. Fox, T. Rakowski, C. Manisty, D. Stassaldi, R. Piazza, L. Spinelli, S. Han, R. Lang, L. Oreto, T. Le Tourneau, L. Li, J. Areias, R. Isnard, D. Silva, Karl Stangl, T. Kukulski, M. Gaspari, A. Tsatsopoulou, Miguel Mota Carmo, P. Pugliatti, A. Atsumi, J. Hammel, J. B. Rius, F. D'auria, O. Ozer, A. Comaglio, Giulio Zucchelli, R. Sicari, P. Claus, D. Horstkotte, A. Di Molfetta, J. De La Hera Galarza, P. Wathen, M. Ganaeem, E. Nyktari, G. Alongi, N. Hayashi, L. Castiglioni, C. El Hamel, A. Melidonis, Y. Seo, M. Cogne, C. Corros, F. Procaccio, L. Fresiello, T. Graven, D. De Guillebon, I. Machado, V. Mor-Avi, R. Rubinshtein, E. Durmus, A. Venkatesh, A. Paini, E. Truemper, A. Aleixo, A. Sahlen, C. Wunderlich, H. Uyarel, R. Ippolito, J. Huhta, D. Morgan, M. Petrovic, G. Cole, C. Piper, N. Zhuravskaya, J. Dubiel, R. Bloise, A. Iniesta Manjavacas, J. Kleinau, J. Lambert Rodriguez, E. Pasanisi, V. Petitalot, D. Beldekos, H. Lim, P. Kleczynski, N. Echahidi, K. Linask, A. Tasal, U. Guerrini, B. Haugen, V. Pereira, M. Banovic, A. Moreo, J. Miralles Ibarra, J F Rodriguez Palomares, C. Park, O. Mjolstad, R. Levine, M. T. G. Alujas, A. Zagatina, M. Martin Fernandez, J. Voigt, E. Psathakis, Y.-Y. Yang, B. Smith, A. Marciniak, T. Yoshikawa, M. Mohammed, C. Aggiusti, H. Tountas, M. Montoro Lopez, M. Guazzi, T. Przewlocki, D. Kim, A. Vannozzi, P. Kogoj, A. Kablak-Ziembicka, S. Goncalves, P. Heilmeyer, S. Censi, J. Kwan, S. Crispo, I. Nogueira, G. Isasti Aizpurua, F. Parthenakis, K. Sveric, O. Uku, F. Anglano, R. Jozwa, A. Karamanou, B. Ozben, M. Delgado, A. Santoro, A. Scafa Udriste, B. Vujisic-Tesic, Y. Kameda, L. Mathias, M. Bongiorni, S. Gianstefani, K.-S. Hsieh, J. Cousins, M. Prull, M. Isailovic-Kekovic, M. Turfan, J. Reiken, R. Muscariello, O. Fernandez Cimadevilla, E. Tremoli, S. Gherardi, F. Musca, S. Kutty, B. Popovic, D. Dudek, L. Gullestad, Michael Laule, A. Almeida, S. Vrakas, C. Santoro, M. Moreno Yanguela, V. Nesvetov, I. Lekakis, V. Mizariene, H. Yamagata, I. Karch, C. Davos, E. Stepien, E. A. Di Panzillo, C. Morisco, S. Kim, M. Takeuchi, R. Del Bene, A. Gaspar, C. Choi, M. Duprey, C. Cefalu, P. Regnier, Q. Ciampi, D. Francis, Gerd Baldenhofer, J. Trochu, A. Dziewierz, T. Bombardini, I. Nedeljkovic, O. Tautu, O. Suhr, M. Enomoto, K.-P. Weng, E. Enache, J. Johnson, J. Legutko, S. Grigoryan, R. Winter, J. Sousa, K. Aonuma, G. Wulf, S. Priori, J. Attebery, A. Squeri, S. Bosi, D. Lavergne, F. Bandera, P. T. Mas, X. Iriart, P. Vardas, A. Brzozowska-Czarnek, B. Trimarco, J. Kasprzak, K. Stuuer, R. Arena, J. O. Na, E. Picano, A. Horovitz, M. Sucu, M. Vatankulu, Vasile Manoliu, Z. Siudak, T. Damy, H. Dores, G. Tsaoussis, Gert Baumann, J. Jakala, Z. Kalarus, R. Jasaityte, G. Dan, K. Takenaka, M. Gurzun, M. Mavroidis, R. Florez Gomez, S. Winter, A. Ebihara, E. Fousteris, N. Catibog, B. Kilickiran Avci, A. Deligiorgis, R. Sharma, A. Alonso Ladreda, M. Dorobantu, Y. Lutay, P. Barbier, O. Jobard, J. Jedrzychowska-Baraniak, M. Perez-Lopez, Y. Yatomi, C. Itziar Soto, P. Polisca, K. Adamyan, B. Putnikovic, M. Lourenco, N. Taha, C. Ebner, K. Obase, P. Podolec, F. Romeo, M. Yamamoto, K. Shahgaldi, T. Edvardsen, C. Leon, A. Varela, A. Anastasakis, D. Oh, I. Di Matteo, A. Manouras, A. Theodosis-Georgilas, J. Bernstein, D. Cini, P. Reant, L. Santini, I. Quelhas, A. Bacaksiz, E. Agabiti Rosei, S. Bartosh-Zelenaya, R. Enache, C. Baicus, G. T. Tura, K. Kimura, R. Esposito, P. Kekovic, A. Whittaker, K. Park, N. Monteforte, S. Foussas, M. Kostkiewicz, S. Damjanovic, T. Ishizu, I. Ene, L. Chiariello, M. van Bracht, L. Segreti, T. Gaspar, A. Neves, M. Estensen, S. Carerj, H. Nesser, K. Yoshida, E. Prappa, S. Connolly, A. Djordjevic-Dikic, A. Calin, P. Carrilho-Ferreira, V. Di Bello, C. Beladan, S. Im, Sebastian Spethmann, S. Hakky, U. Trecroci, S. Tamai, L. Wrotniak, J. Necas, H. Marques, A. Neskovic, K. Skjetne, M. Galderisi, V. Ruddox, C. Adam, J. Leshko, H. Le Marec, A. Mateescu, L. Tunyan, F. Baeza, R. De Lucia, S. Aakhus, W. Serra, D. Simion, I. Stankovic, L. G. Garcia-Moreno, S. Sahin, P. Seferovic, M. Casartelli, E. Nobili, J. Marques, V. Davutoglu, O. Goktekin, C. Ginghina, D. Gemma, C. Yodwut, T. Sakakura, M. Nedeljkovic, S. Viani, H. Von Bibra, N. Protonotarios, R. Onut, H. Dalen, E. Romo, S. Woo, M. Franzosi, D. Zamfir, P. Ierano, J. S. De Lezo, E. Yeager, H.-J. Trappe, F. Pereira Machado, S. Grego, C. Gronlund, J. O'driscoll, C. Tsilafakis, L. Carpinteiro, L. Sironi, B. Diaz Molina, V. Probst, P. Sousa, N. Hammoudi, S. Kovalova, L. Paperini, M. Lunati, H. Seo, G. Ferrari, J. Roquette, F. Toledano, R. Jurkevicius, G. Nicolosi, D. Mohty, V. Giga, R. Sachner, T. Butz, F. Pousset, O. Sonmez, N. Reckefuss, O. Vriz, G. Dobson, J. Zdzienicka, V. Labate, F. Pinto, C. Jorge, F. Purcarea, T. Wutthachusin, R. Strasser, I. Kostavassili, M. Szulik, D. Danford, J. Vignalou, D. Popovic, M. Ruiz Ortiz, B. Popescu, O. Guseva, J. Rios Blanco, S. Purkayastha, D. Zaliaduonyte-Peksiene, J. Lopez Sendon, A. Magalhaes, G. Plehn, A. Tanrikulu, D. Mesa, G. Di Bella, D. Muraru, M. Salvetti, A. Arandjelovic, and M. Costantino

Subjects
medicine.medical_specialty, business.industry, Alternative medicine, Physical therapy, Medicine, Radiology, Nuclear Medicine and imaging, General Medicine, Session (computer science), Cardiology and Cardiovascular Medicine, business
Published
2012
Full Text
View/download PDF

5. Kinetics of hepatitis B virus load and haemodialysis: a prospective study

Author

E. Corghi, Fabrizio Fabrizi, Paul Martin, Filippo Aucella, P. Faranna, G. Alongi, S. Mangano, S. Bisegna, G. Romei-Longhena, Francesco Barbisoni, and Giovanna Lunghi

Subjects
Hepatitis B virus, HBsAg, Hepatology, business.industry, medicine.medical_treatment, Maintenance haemodialysis, virus diseases, Hepatitis B, medicine.disease_cause, medicine.disease, digestive system diseases, Titer, Infectious Diseases, Virology, Immunology, medicine, business, Prospective cohort study, Viral load, Dialysis
Abstract

The control of the spread of hepatitis B virus (HBV) infection within dialysis units has been an important goal in the management of patients on regular dialysis but infected patients continue to enter the dialysis system. It is evident that HBV viraemia in hepatitis B surface antigen (HBsAg)-positive patients on dialysis is low but it remains unclear whether haemodialysis per se can contribute to viral load reduction in such patients. HBV DNA was determined in 40 HBsAg-positive patients on maintenance haemodialysis immediately before and at the end of a 4-h haemodialysis session. The same measurements were repeated 48 and 72 h later. Twenty (50%) of 40 HBsAg-positive patients had detectable HBV DNA in serum. Detectable HBV DNA in serum was not predicted by demographic, clinical or biochemical parameters. HBV load decreased in the majority of patients after haemodialysis, although the difference was not significant (29 390 +/- 48 820 vs 23 862.8 +/- 4 350 copies/mL, NS). There was a strong relationship between mean HBV DNA levels before dialysis and absolute reduction of HBV DNA during haemodialysis sessions (r = 0.75, P = 0.0001). No difference occurred in the magnitude of change in HBV DNA titre when comparing cellulosic to synthetic membranes. Haemodialysis per se leads to a reduction in HBV load in HBsAg-chronic carriers on maintenance dialysis. This phenomenon could explain the low viral loads in these patients. Prospective studies are in progress to identify the mechanisms responsible for reduction in HBV load during haemodialysis.

Published
2008
Full Text
View/download PDF

6. Endoscopic screening of the upper and lower digestive tract of the patients with chronic renal failure on waiting list for renal transplantation

Author

Gerlando Cocchiara, G. Iatrino, Maurizio Romano, G. Alongi, G. Falcone, Giuseppe Buscemi, Salvatore Buscemi, Giorgio Romano, Fiorella Calderone, Antonino Agrusa, ROMANO G, G COCCHIARA, F CALDERONE, A AGRUSA, G ALONGI, S BUSCEMI, GFALCONE, G IATRINO, M ROMANO, and G BUSCEMI

Subjects
Transplantation, medicine.medical_specialty, Hepatology, business.industry, Waiting list, Gastroenterology, Medicine, Chronic renal failure, Digestive tract, Endoscopic screening, business, Intensive care medicine
Published
2006
Full Text
View/download PDF

7. Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223

Author

Clizia Zichi, Pierpaolo Alongi, Salvatore Antonio Pignata, Luca Galli, Stefania Agostini, Massimiliano Spada, Sabrina Rossetti, Fabio Monari, Angelina Filice, Sergio Baldari, Elisa Biasco, Viviana Frantellizzi, Giuseppe De Vincentis, Marcello Tucci, Eugenio Borsatti, Cristina Masini, Enrico Cortesi, Gaetano Facchini, Stefano Fanti, Roberto Bortolus, Orazio Caffo, and Caffo O, Frantellizzi V, Tucci M, Galli L, Monari F, Baldari S, Masini C, Bortolus R, Facchini G, Alongi P, Agostini S, Zichi C, Biasco E, Fanti S, Pignata S, Filice A, Borsatti E, Rossetti S, Spada M, Cortesi E, De Vincentis G.

Subjects
Radium-223, Male, medicine.medical_specialty, Abiraterone, Fracturative risk, Radium 223, Safety, Sequencing, Abiraterone Acetate, Bone Neoplasms, Neutropenia, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Risk factor, Survival rate, Retrospective Studies, business.industry, Abiraterone acetate, General Medicine, medicine.disease, Surgery, Prostate-specific antigen, Prostatic Neoplasms, Castration-Resistant, Zoledronic acid, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, business, medicine.drug, Radium
Abstract

Purpose: To evaluate the fracture risk and survival outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) who received sequentially abiraterone acetate (AA) and radium 223 [223Ra]RaCl2 in the daily clinical practice. Materials: We retrospectively reviewed the records of mCRPC patients who received [223Ra]RaCl2 immediately after progressing during an AA treatment line in everyday clinical practice. Results: We reviewed data of a consecutive series of 94 mCRPC patients. Most of the patients (85.1%) received [223Ra]RaCl2 as second- or third-line treatment. [223Ra]RaCl2 treatment was well-tolerated; there were only four cases of grade 3 anaemia, two cases of grade 3 leukopenia and one case of grade 3 neutropenia. The overall fracture rate is 2.1%; one fracture was recorded during the course of [223Ra]RaCl2 treatment, and one was recorded 1 month after its end. The fractures both occurred at metastatic sites. Median OS from [223Ra]RaCl2 start was more than 14 months regardless of the treatment line when [223Ra]RaCl2 was administered. Conclusion: The findings of this study show that the treatment with [223Ra]RaCl2 immediately after AA was active and safe with a very low risk of a fracture. Thus, the present observational report makes a valuable contribution to the current debate concerning the risks and benefits of including [223Ra]RaCl2 in the therapeutic algorithm.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results